New PKU drug JNT-517 moves to Long-Term safety check in phase 3 trial
NCT ID NCT06628128
First seen Apr 29, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This study tests the long-term safety of an experimental drug called JNT-517 in children and adults with PKU, a genetic condition that causes harmful buildup of phenylalanine. All 240 participants will receive the drug, and researchers will monitor side effects and changes in blood phenylalanine levels. The goal is to see if JNT-517 is safe enough for ongoing use to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA (PKU) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Health Queensland - Queensland Children's Hospital
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Children's Medical Center Dallas
RECRUITINGDallas, Texas, 75235, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mater Health - Mater Hospital Brisbane
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Murdoch Children's Research Institute
RECRUITINGParkville, Victoria, 3052, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oregon Health and Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Florida (UF) Health Shands Hospital
RECRUITINGGainesville, Florida, 32608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of South Florida
RECRUITINGTampa, Florida, 33606, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Texas Health (UTHealth) Science Center at Houston
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Utah Health - The University of Utah Hospital
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.